Immunotherapy for malignant glioma

Malignant gliomas (MG) are the most common type of primary malignant brain tumor. Most patients diagnosed with glioblastoma (GBM), the most common and malignant glial tumor, die within 12–15 months. Moreover, conventional treatment, which includes surgery followed by radiation and chemotherapy, can...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Surg Neurol Int
Main Authors: Suryadevara, Carter M., Verla, Terence, Sanchez-Perez, Luis, Reap, Elizabeth A., Choi, Bryan D., Fecci, Peter E., Sampson, John H.
Formato: Artigo
Idioma:Inglês
Publicado em: Medknow Publications & Media Pvt Ltd 2015
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4338494/
https://ncbi.nlm.nih.gov/pubmed/25722935
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/2152-7806.151341
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Internet

https://ncbi.nlm.nih.gov/pmc/articles/PMC4338494/
https://ncbi.nlm.nih.gov/pubmed/25722935
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/2152-7806.151341